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ScienceDirectTowards the understanding of the behavior of bio-based
nanostructures during in vitro digestion
Ana C Pinheiro1,2, Raquel FS Gonc¸alves1,
Daniel A Madalena1 and Anto´nio A Vicente1The encapsulation of bioactive compounds in bio-based
nanostructures is considered a hot topic in food technology,
due to their huge potential in protecting the valuable bioactive
compounds and providing new functionalities (e.g. increase of
bioavailability). However, there are still some challenges that
must be overcome before this technology can be entirely
embraced by food industry, including the optimization of
nanostructures’ formulations to increase stability and bioactive
compounds’ bioavailability and the risk assessment of their use
in food. Therefore, in recent years, efforts are being directed to
the evaluation of the in vitro behavior of nanostructures during
digestion/absorption. This evaluation can be challenging,
however, there are opportunities to take advantage from the
lessons learned from pharmaceutical industry and of the
considerable progress in the development of more realistic in
vitro models and in situ analysis techniques to more accurately
predict the behavior of bio-based nanostructures once
ingested.
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The increase in consumers’ awareness of the impact that
food has on health has spurred the development of
functional foods, that is, food containing bioactive com-
pounds (e.g. carotenoids, vitamins, fatty acids, polyphe-
nols, bioactive peptides, phytosterols, fibers and essential
minerals) dispersed within their matrix. However, most
bioactive compounds present low water solubility, poorwww.sciencedirect.combioavailability, sensitivity to deterioration during proces-
sing, shelf-life and digestion, and/or unpleasant sensory
attributes, and therefore cannot be added directly into
foods [1]. Delivery systems at nano-scale have attracted
considerable interest worldwide over the past decade, due
to their potential to enhance the bioactive compounds’
bioavailability (i.e. amount of ingested bioactive com-
pound that is absorbed and available for physiological
functions) and stability, with minimal adverse sensory
effects. However, alongside their great potential, nanos-
tructures for food applications are also facing some con-
cerns about possible toxicity. Only through the
understanding of the digestive fate of nanostructures/
bioactive compounds it is possible to improve their per-
formance and to conclude about nanostructures’ safety.
The present review highlights the latest (past 2–3 years)
important advances in the development of bio-based
delivery systems at nanoscale and in unraveling their
behavior within the gastrointestinal (GI) tract, including
an insight into the challenges associated with this in vitro
evaluation and potential future directions (e.g. develop-
ment and use of more sophisticated dynamic in vitro
digestion models).
Bio-based nanostructures for encapsulation
of bioactive compounds
By contrast to pharmaceutical industry, nanostructures for
food applications must be entirely produced with food
grade ingredients (e.g. lipids, proteins, polysaccharides,
surfactants) and through approved processing operations
(e.g. mixing, homogenizing thermal processing) [2]. Be-
cause of this reason, there is an increasing interest in
founding new natural ingredients to produce bio-based
nanostructures with good properties to incorporate in food
products without interfering with their sensory character-
istics.
There have been major advances in the design and
production of bio-based nanostructures to encapsulate
bioactive compounds for food applications. Till date,
different bio-based nanostructures have been described
in the available literature, including nanoemulsions, lipo-
somes, nanostructured lipid carriers, polymeric nanopar-
ticles, protein–polysaccharide complexes and
nanohydrogels. These bio-based nanostructures present
different sizes, structures, compositions and physico-
chemical properties and can offer numerous functionali-
ties. Also, they typically present as principal advantagesCurrent Opinion in Food Science 2017, 15:79–86
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provement of oral absorption and controlled/sustainable
release [3]. Also, bio-based nanostructures can be espe-
cially formulated to survive passage through different
regions of the GI tract and then release the bioactive
compounds at a specific location, thus maximizing their
potential health benefits [4]. Some recent developments
on nanoencapsulation of bioactive compounds for food
applications, with special emphasis to their outcomes, can
be found in Table 1.Table 1
Recent advances in the development of bio-based nanostructures for
Nano-delivery system Bioactive compound Nanostructure mat
Nanoemulsions Astaxanthin
Lycopene
Linseed oil
Tween 20
Pterostilbene Olive oil
Flaxseed oil
Tween 20
Liposomes Fish oil Soy lecithin
Sunflower oil
Catechin
Epigallocatechin
gallate (EGCG)
Soy lecithin
Nanostructured lipid
carriers
Terpene Beeswax
MCT
Alkylpolyglucoside
Vitamin D3 Oleic acid
Glycerol monosteara
Tween 80
Polymeric nanoparticles Curcumin Chitosan
Gum arabic
Tween 80
Egg yolk phospholip
CoQ10 Octenyl succinic anh
modified starch (OS
Rice bran oil
Current Opinion in Food Science 2017, 15:79–86In the past years, there has been a tendency to design new
bio-based nanostructures through the combination of
existent nanomaterials (lipids and polymers), promoting
a synergistic interaction between these nanomaterials.
Furthermore, the development of new delivery systems,
such as the combination of two (nano)structures (e.g.
nanoparticles trapped within hydrogel beads [16]) could
be a new approach for encapsulation of bioactive com-
pounds with more stability, protection and efficient con-
trol release in food products.encapsulation of bioactive compounds for food applications
erials Outcomes Reference
U Higher stability to storage and
environment conditions for emulsions with
size lower than 200 nm
U Incorporation of combined antioxidants
increase the oxidative stability
U Higher bioaccessibility of carotenoids
encapsulated in nanoemsulsions
[5]
U Higher percentage of FFA released for
olive oil
U Similar bioaccessibility of pterostilbene
for olive oil and flaxseed oil nanoemulsions
U Potential enhancement of the
permeability of the tight junctions for olive
oil nanoemulsions
[6]
U Encapsulation efficiency 92%
U Good stability
U Incorporation in yogurt did not affect its
sensory quality and protected the fish oil
[7]
U High retention of bioactive compounds
in the cheese structure
U Increase of the antioxidant activity and
total phenolic content without affecting the
cheese characteristics
U Good protection of bioactive
compounds
[8]
U Good stability
U High loading capacity
U Biphasic release: burst release and
sustained release
U Profile release dependent on chemical
structure of terpenes
[9]
te
U High encapsulation efficiency, that is
not affected by differences in pH
U High stability in acidic conditions, but
instable in alkaline conditions
U Good storage stability
U Capability to control release
[10]
id
U High encapsulation efficiency and
loading capacity
U Good physical stability
U Improvement of antioxidant activity
U Enhancement of delayed release in
GI tract
[11]
ydride
A-ST)
U Good thermal and pH stability
U Encapsulation efficiency 98.2%
U Suitable for use in beverages, fruit
juices and baked goods
[12]
www.sciencedirect.com
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Table 1 (Continued )
Nano-delivery system Bioactive compound Nanostructure materials Outcomes Reference
Nanohydrogels Curcumin
Caffeine
Lactoferrin
Glycomacropeptide
U Capability to incorporate hydrophilic
and lipophilic compounds
U High encapsulation efficiency
U Enhancement of bioactive compounds’
antimicrobial activity
U Bioactive compounds’ release
dependent on pH
[13]
b-Carotene WPI
Alginate
U Better chemical stability than
nanoemulsions during storage and
within GI tract
U Lower bioaccessibility than
nanoemulsions
U Useful for delivering bioactive
compounds in the large intestine
[14]
Protein-polysaccharide
complexes
Fish oil Sodium caseinate
Gum arabic
U Encapsulation efficiency 78.9%
U Successful incorporation within juice fruit
U Juice fruit enriched with oil fish
nanoencapsulated presented a
bioaccessibility 47.4%
[15]The selection of the most appropriate bio-based nano-
structure for a particular application requires an under-
standing of the bioactive compound properties and of the
nature of the food matrix in which it will be incorporated,
as well as on their behavior within the GI tract.
Gastrointestinal fate of bio-based
nanostructures/bioactive compounds
Bio-based nanostructures undergo a series of complex
physicochemical and physiological processes as they pass
through the different regions of the GI tract, before the
release of the bioactive compound (Figure 1). Some of the
key processes are (i) consecutive changes in the pH of the
medium, which could alter nanostructures’ electrical
charge, and consequently their composition, structure
and interactions; (ii) variations in the type and concentra-
tion of ions, which may impact the electrostatic interac-
tions in the nanostructure through electrostatic screening
or binding effects; (iii) presence of surface-active compo-
nents (e.g. phospholipids and bile salts), which could lead
to changes in nanostructures’ interfacial composition; (iv)
presence of enzymes able to digest components of the
bio-based nanostructure, such as lipids (lipases), phos-
pholipids (phospholipases), proteins (proteases), and
starch (amylases); (v) temperature, which may cause
changes in the physical state, molecular conformation
or interactions of specific components, impacting nanos-
tructures’ digestibility; and (vi) flow/force profile which,
besides mixing the various components, could lead to the
breaking down of the delivery system’s structure.
Different strategies have been used to control nanostruc-
tures’ fate in the GI tract. For example, enzyme accessi-
bility to a nanostructure may be controlled by creating
physical barriers between the nanostructure and the
surrounding aqueous phase containing the digestivewww.sciencedirect.comenzymes. It has been demonstrated that emulsions’ be-
havior during digestion can be modulated by coating
them with biopolymers [17], nanostructures [18] or con-
jugates [19].
Thus, the biological fate of bio-based nanostructures will
be dependent not only on their initial physicochemical
characteristics (e.g. composition, size, structure, interfa-
cial properties and physical state), but also on the exten-
sion of the changes experienced as they pass within the
GI tract. It is know that at nanoscale, the biological fate of
the delivery systems and bioactive compounds incorpo-
rated within may be altered, influencing their absorption,
distribution, metabolism and excretion, and consequently
their potential toxicity [20]. However, in contrast to
inorganic nanoparticles (e.g. gold, silver), the absorption
of intact bio-based nanostructures into the systemic cir-
culation is unlikely, due the changes after undergone
gastric and intestinal digestion, being their accumulation
in the organs, and consequent toxic effect, also improba-
ble. In any case, the transformation and retention of bio-
based nanostructures are related to their physicochemical
properties, and therefore, the evaluation of their safety
must be done in case-by-case basis.
Regarding the bioactive compounds, different mecha-
nisms can be involved in their release from nanostructures
(e.g. diffusion, swelling, erosion, fragmentation, dissolu-
tion, stimuli response) and, depending on the system and
environmental conditions, a different mechanism may
prevail [21]. Two main transport mechanisms can be
involved in their passage across the intestinal epithelium:
(1) between cells via tight junctions — paracellular route
or (2) through intestinal membrane cells — transcellular
route [22]. The bioactive compounds can undergo chem-
ical degradation under harsh GI conditions or may beCurrent Opinion in Food Science 2017, 15:79–86
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Figure 1
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Physiological and physicochemical changes that bio-based nanostructures can undergo as they pass through the GI tract.metabolized by different enzymes during their passage
from the GIT tract, to the epithelium cells, and then into
the systemic circulation, leading to low bioavailability.
Understanding of the GI fate of bio-based nanostructures
is therefore required to predict and increase their func-
tionality (i.e. bioavailability of the bioactives compound)
and to evaluate their potential toxicity.
Strategies for the enhancement of the bioactive
compounds’ bioavailability
Bioavailability is known to be dependent on the bioactive
compounds’ bioaccessibility, intestinal absorption and
transformation in the GI tract [23]. The improvement
of the bioavailability of a bioactive compound is essential
to maintain their bioefficiency, that is, their health ben-
efits. Several approaches have been used for the improve-
ment of bioavailability of food bioactive compounds, mostCurrent Opinion in Food Science 2017, 15:79–86of them translated from pharmaceutical drug research.
However, in order to establish a successful strategy to
enhance the bioavailability of the bioactive compounds it
is important to know the main factors limiting their
bioavailability.
The use of nanoscale delivery systems can be per se a
strategy to increase the bioavailability of different bioac-
tive compounds, once they could facilitate the entering of
the bioactive compounds through biological barriers, as
well as avoiding their metabolic modifications. In fact,
nanostructures such as nanoemulsions or solid lipid nano-
particles have been shown to increase the bioavailability
of different lipophilic bioactive compounds [24,25].
Also, there is a high potential to further increase the
bioactive compounds’ bioavailability through the im-
provement of their intestinal permeability, which canwww.sciencedirect.com
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in the delivery systems’ formulation. Different food-
grade compounds, including bile salts, surfactants, fatty
acids, polymers and herbal bioactives have shown the
ability to improve the intestinal absorption of bioactive
compounds [26]. The mode of action of absorption
enhancers can be either paracellular, by the opening of
tight junctions, or transcellular by increasing the plasma
membrane permeability, or a combination of both [27].
Other potential approach to improve the bioavailability of
bioactive compounds is the inhibition of intestinal cell
transporters (e.g. ATP binding cassette (ABC) transport
proteins) once they can be involved in the efflux of
bioactive compounds back into the intestinal lumen,
reducing bioavailability [28].
Moreover, the co-ingestion of bioactive compounds with
excipient foods is also a bioavailability enhancement
strategy that has gained much attention in the recent
years. In this case, the bioactive compound (that might be
left in its natural source) is consumed with an excipient
food specially formulated to control bioactive com-
pounds’ release, solubilization, transport, metabolism
and absorption within the GI tract, boosting their bio-
availability [29]. In fact, it has been suggested that
delivery systems containing mixed colloidal particles
(protein and lipid nanoparticles) may be designed to
increase the chemical stability and bioaccessibility of
lipophilic bioactive compounds [30].
Challenges in tracking bio-based nanostructures
digestion
There are still some challenges that must be overcome
regarding the evaluation of bio-based nanostructures dur-
ing digestion. For instance, digestion secretions (i.e.
presence of enzymes, salts and bile salts), sample dilution
(during digestion) and sample preparation (e.g. centrifu-
gation) may influence the overall results obtained from
the in vitro digestion (e.g. bioavailability determination or
bio-based nanostructure tracking).
Centrifugation [31,32,33] and sample dilution [33] are
often used as a pre-treatment, prior to sample analysis
regarding spectrometry (i.e. spectrophotometry, spec-
trofluorimetry), chromatography (i.e. HPLC) and struc-
tural (i.e. DLS) analysis, respectively. Digestion
samples may also be submitted to oxygen and light
exposure, and temperature and pH variations, prior to
analysis. For instance, in vitro digestion protocols often
include an enzymatic deactivation step that may alter
the structure of the assessed bio-based nanostructures or
the bioactive compounds’ activity. In fact, it is a com-
mon practice to submit digestion samples to low tem-
peratures (i.e., through ice or liquid nitrogen) to slow the
enzymatic digestion rates. Samples are also often sub-
mitted to high temperatures (i.e. 100 8C) to stop
enzymes’ activity.www.sciencedirect.comMoreover, due to the complexity of the mixture after
digestion, a separation and purification step are often
required. Several methods can be used for separation
and purification of bio-based nanostructures after diges-
tion simulation, including asymmetrical flow field flow
fractionation [34]. It is expected that in the next few
years, new reliable methods for the detection and char-
acterization of nanostructures under different conditions
are established, improving the traceability of nanostruc-
tures within the human body.
Despite the fact that these procedures are in fact crucial to
determine bioactive compounds’ bioavailability and
nanostructures behavior under digestion, they can also
be considered as a bottleneck that needs to be addressed
to minimize misconceptions and false results. In situ
analysis can solve some of the challenges discussed above
since it does not require sample pre-treatment procedures
and gives more reliable information, in real time, regard-
ing nanostructural changes during digestion so that cor-
relations can be made toward bioactive compounds’
bioavailability. Recently, a ‘real-time quantitative meth-
od’ to track the structural changes that occur in emulsion
interface, during in vitro intestinal conditions has been
developed and these changes were correlated with the
release of free fatty acids. The authors used fluorescent
resonant energy transfer (FRET) to evaluate, in situ, the
emulsion digestion under simulated intestinal conditions
[35].
Recent advances in the development of
in vitro GI systems
In vitro GI models are currently used as the main tool to
understand the behavior of bio-based nanostructures
under GI conditions, minimizing the negative implica-
tions associated with in vivo studies (i.e., ethical, econom-
ical and technical constrains). However, these models are
usually simple in vitro static models due to their lower cost
and simplicity regarding protocol execution [36,37]. Only
recently, dynamic in vitro GI models are being used to
evaluate the behavior of bio-based nanostructures during
digestion [38,39]. There is an ongoing awareness to
developed more realistic in vitro GI models to study,
not only food digestion, but potentially the behavior of
nanostructures, reproducing the phenomena that occur
during human digestion (e.g. gastric peristaltic move-
ments) [40,41].
Recently an ‘in vitro mechanical gastric system’ (IMGS —
Figure 2a) using 3D printing technology has been devel-
oped. The authors used natural liquid latex and the model
was coupled with four pairs of acrylic pistons, arranged on
each side of 3D printed stomach to reproduce three
contractions per minute. This system enables the study
of important phenomena (i.e., propulsion, grinding and
retropulsion) that occur during gastric digestion [40].
Other authors developed an ‘in vitro gastric device’Current Opinion in Food Science 2017, 15:79–86
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Figure 2
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In vitro gastric models containing different mechanisms to simulate the human gastric peristaltic movements where (a) represents the IMGS, (b)
represents the in vitro gastric device and (c) represents the TIMagc (reprinted from References [40,42,41], respectively, Copyright 2017, with
permission from Elsevier (a and c) and Dissolution Technologies, Inc. (b)).coupled with a peristaltic mechanical system consisting in
a three belt apparatus (Figure 2b). The authors used latex
to achieve the appropriate deformation characteristics of
the human stomach, with an oval shape. The belts were
strategically positioned at the top, middle and bottom of
the stomach model, reproducing three contractions per
minute [42]. Also, an ‘advanced gastric compartment’
(TIMagc — Figure 2c) has been developed to study food
gastric digestion. The authors built three compartments
simulating the gastric body, proximal and distal antrum
and the model was coupled with a valve to mimic the
pyloric sphincter. The stomach peristalsis was simulated
by synchronously contracting inner membranes on each
compartment, simulating the human stomach motility
[41].
The development of novel gastric systems that mimic
both the anatomy and peristaltic gastric movements that
occur during in vivo digestion is showing to be a current
trend. These models use extensive in vivo data to recreate
the conditions of the human stomach regarding pH vari-
ation during bolus digestion, stomach motility and secre-
tion composition.
Recent advances were also observed regarding cellular
studies, as a means to study bioactive compounds per-
meability in the small intestine. A tissue-engineered
model has been established, by co-culturing Caco-2 ab-
sorptive cells, HT29-MTX mucus-producing cells and
Raji B lymphocytes and the presence of M-cells (derived
from stem cells) has been accessed [43]. The authors
concluded that the presence of M-cells improved theCurrent Opinion in Food Science 2017, 15:79–86bioactive compound transport efficiency, showing to be
a more complete and reliable tool to perform permeability
tests.
Despite the recent advantages in the field, there are still
some bottlenecks that need to be addressed regarding the
evaluation of bio-based nanostructures behavior under
digestion. For instance, there is still a lack of agreement
regarding the standardization of in vitro digestion proto-
cols (i.e., both static and dynamic), despite the efforts of
the COST action INFOGEST [34], so that inter-labora-
tory results can be compared and correlations can be
established.
Conclusions and future trends
This review focus on the recent advances on the devel-
opment of bio-based nanostructures for encapsulation of
bioactive compounds, with special emphasis to their
behavior under GI digestion. Efforts are being directed
to the development of the next-generation delivery sys-
tems, with maximum functionality. Some examples can
include mixed nanoparticle systems, nanoclusters, Tro-
jan-horse nanoparticles and environmentally responsive
nanoparticles.
However, there is still a lack of knowledge on the behav-
ior of the nanostructures/bioactive compounds encapsu-
lated in the GI tract, in particular on their potential
adverse effects on human health. In order to respond
to this concern, more realistic in vitro digestive/absorption
models and more advanced analytical methods need to be
developed, in order to understand the fate of nanostruc-www.sciencedirect.com
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tructures with increased functionality and predicting the
consequences of their intake. Even when using simple in
vitro models, there is an evident need to develop stan-
dardized methods (e.g. for measure the bioavailability of
bioactive compounds) that could allow a more accurate
comparison of results between different laboratories.
Finally, but not less important, a clear legislation and
guidelines concerning their impact on human health and
on environment must be assured. Although the regulatory
framework on the use of nanostructures in foods is still in
flux, it is expected an increase of control and regulation to
assure the proper development and utilization of bio-
based nanostructures in foods.
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